BOSTON BIO SYSTEMS LTD. Share Price Today | Stock Price & BOSTON BIO SYSTEMS LTD. Share Screener
As of February 18, 2026, the live BOSTON BIO SYSTEMS LTD. share price (BSE: BOSTONBIO) is ₹5.39, down 4.94% from the previous close, with shares trading between ₹5.39 and ₹5.39 in today's trading session, and a 52-week range of ₹5.39–₹10.46. Check BOSTON BIO SYSTEMS LTD. yearly highs lows for the annual price range and momentum. Use the BOSTON BIO SYSTEMS LTD. stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today BOSTON BIO SYSTEMS LTD. opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹1 and net income of ₹-1, an operating margin of -33.0% and a profit margin of -100.0%.
BOSTON BIO SYSTEMS LTD. Share Price Chart
Track the current stock price of BOSTON BIO SYSTEMS LTD. with an interactive chart. Analyse BOSTONBIO share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete BOSTON BIO SYSTEMS LTD. stock quote in one place.
The quote of ₹5.39 sits between the 52-week low of ₹5.39 and the 52-week high of ₹10.46, and the latest session moved -4.94% from the previous close.
BOSTON BIO SYSTEMS LTD. Company Profile - Fundamental Screener
Screen BOSTON BIO SYSTEMS LTD. company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for BOSTONBIO shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare Services sector and the Healthcare Service Provider industry, and it trades under ISIN INE109B01019.
Company Details
Classification
Identifiers and Leadership
BOSTON BIO SYSTEMS LTD. Balance Sheet Screener
Screen BOSTONBIO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2025, total assets were ₹15 against total liabilities of ₹15, up from ₹11 in 2024.
Latest statistics put total assets at ₹15 and shareholder funds at ₹6, with a leverage ratio of 0.51.
| Item | 2025 | 2024 | 2023 | 2022 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|
Assets |
||||||||
| Total Assets | 15 | 11 | 11 | 11 | 10 | 9 | 9 | 7 |
| Current Assets | 9 | 5 | 5 | 5 | 4 | 4 | 3 | 1 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Liabilities |
||||||||
| Total Liabilities | 15 | 11 | 11 | 11 | 10 | 9 | 9 | 7 |
| Current Liabilities | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||
| Total Equity | 6 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Share Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves & Surplus | -1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 |
BOSTON BIO SYSTEMS LTD. Income Statement Screener - Profit & Revenue Analysis
Screen BOSTON BIO SYSTEMS LTD. income statement and profit fundamentals. Analyze BOSTONBIO quarterly results. BOSTON BIO SYSTEMS LTD. reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹1 and net profit was ₹-1, equal to earnings per unit of ₹-0.60, at an operating margin of -33%.
In that period expenses were ₹1, interest cost ₹0 and tax ₹0. The next period listed, 2025-March, shows revenue of ₹0 and net profit of ₹-1.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||
| Revenue | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 0 |
| Expenses | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 2 | 0 |
Operating Costs and Margins | |||||||||
| EBITDA | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit % | -33.00% | -284.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | |||||||||
| Profit Before Tax | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | -0.60 | -0.78 | -0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
BOSTON BIO SYSTEMS LTD. Cash Flow Screener - Liquidity Fundamentals
Screen BOSTONBIO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2025-March, operating activities used ₹5.
Over the same period, investing activities provided ₹0 and financing activities provided ₹5.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||
| Operating Activities | -5 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 |
Financing and Net Cash | ||||||||
| Financing Activities | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
BOSTON BIO SYSTEMS LTD. Shareholding Pattern Screener
See BOSTON BIO SYSTEMS LTD. shareholding pattern with promoter, FII, and DII holdings. Check BOSTON BIO SYSTEMS LTD. promoter holding and ownership changes for BOSTONBIO on TickJournal, and see how institutional stock price moves affect the market.
In 2025-Mar, promoters held 2.14%, foreign institutions 0.00%, domestic institutions 0.00% and the public 84.78%, spread across 1,147 shareholders.
The shareholder count was 1,147 in 2025-Mar, compared with 1,295 in 2025-Jun.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 2.14% | 2.14% | 2.14% | 2.14% | 2.14% | 2.14% | 2.14% | 2.14% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 84.78% | 85.33% | 85.21% | 84.81% | 85.14% | 85.14% | 85.14% | 85.14% |
| Other Holding | 13.08% | 12.53% | 12.64% | 13.05% | 12.72% | 12.72% | 12.72% | 12.72% |
| Shareholder Count | 1,147 | 1,295 | 1,385 | 1,410 | 1,141 | 1,141 | 1,141 | 1,141 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by BOSTON BIO SYSTEMS LTD.. BOSTON BIO SYSTEMS LTD. dividend yield can be compared with peers and other stocks in the market.
BOSTON BIO SYSTEMS LTD. Stock Index Membership - Nifty & Sensex
See which indices include BOSTON BIO SYSTEMS LTD. stock. Check BOSTONBIO index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
BOSTON BIO SYSTEMS LTD. Market Events Screener - Corporate Actions
Get BOSTON BIO SYSTEMS LTD. corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check BOSTON BIO SYSTEMS LTD. stock events that may affect BOSTONBIO share price, along with derivatives, futures and options activity and sector gainers.
9 corporate actions are listed, the most recent entry being Annual General Meeting dated .
It is followed by Annual General Meeting dated and Annual General Meeting dated .
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -1.09% | ||
| Annual General Meeting | NA | - | ||
| Annual General Meeting | NA | - | ||
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | -0.15% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -4.80% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 1.91% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -3.84% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | - |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | - |
BOSTON BIO SYSTEMS LTD. Competitors Screener - Peer Stocks Comparison
Screen BOSTONBIO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 24,049 | 44.70 | 2,555 | 11.28% | 492 | 48.89 |
| Vijaya Diagnostic Centre | 10,510 | 64.84 | 700 | 23.06% | 144 | 54.52 |
| Metropolis Healthcare | 10,014 | 59.24 | 1,346 | 10.64% | 146 | 51.03 |
| Thyrocare Technologies | 6,576 | 47.68 | 702 | 20.80% | 91 | 41.10 |
| Nephrocare Health Services | 5,655 | 78.19 | 770 | 33.97% | 67 | 61.79 |
| Krsnaa Diagnostics | 2,181 | 26.87 | 743 | 16.70% | 78 | 32.82 |
| One Global Service Provider | 1,485 | 24.59 | 148 | 134.60% | 19 | 75.94 |
| Suraksha Diagnostic | 1,480 | 45.74 | 256 | 15.11% | 31 | 60.11 |
| 3B BlackBio DX | 1,358 | 23.40 | 112 | 28.72% | 48 | 50.23 |
| Sastasundar Ventures | 942 | 32.79 | 1,171 | -18.47% | -134 | 47.24 |
BOSTON BIO SYSTEMS LTD. Company Announcements - News & Reports Screener
Screen BOSTONBIO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated February 22, 2026.
The next most recent announcements are dated February 21, 2026 and February 21, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-02-22 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-21 | Unaudited Financial Results For The Quarter Ended 31St December 2025 | - |
| 2026-02-21 | Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th February 2026 Pursuant To Regulation 30 Of SEBI(Listing Obligation And Disclosure Requirements)Regulation 2015 | - |
| 2026-02-18 | Board Meeting Intimation for Prior Intimation For The Board Meeting To Be Held On 13Th February 2026 | - |
| 2026-01-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-30 | Closure of Trading Window | - |
| 2025-11-27 | Announcement under Regulation 30 (LODR)-Change of Company Name | - |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-14 | Considered And Approved The Standalone Un-Audited Financial Results Of The Company For The Quarter And Half Ended On 30Th September 2025. | - |
| 2025-11-14 | Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligation & Disclosure Requirements) Regulation 2015 Held Today I.E. 14Th November 2025 | - |
| 2025-11-07 | Board Meeting Intimation for Prior Intimation Of Date Of Board Meeting For Considering The Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025. | - |
| 2025-10-14 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-10-13 | Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th October 2025 Regarding Change In Management- Resignation And Appointment Of Company Secretary | - |
| 2025-10-11 | Reg. 34 (1) Annual Report. | - |
| 2025-10-03 | Reg. 34 (1) Annual Report. | - |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2025-09-26 | Closure of Trading Window | - |
| 2025-09-05 | Intimation For Book Closure | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹5.39, within a 52-week range of ₹5.39 to ₹10.46. The P/E ratio is -9.77 and the P/B ratio is 0.70, with earnings per unit of ₹-0.78. Market capitalisation stands at ₹4.20 Cr. The company operates in the Healthcare Services sector, in the Healthcare Service Provider industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on February 24, 2026. This page covers 8 balance sheet periods, 9 income statement periods, 8 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.